Fund Card

Fund Card

ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)

As on Mar-05-2021 change fund
17.35  down-0.22 (-1.25%)

fund objective

To generate long-term capital appreciation by creating a portfolio that is invested in Equity and Equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.However there can be no assurance that the investment objectives of the scheme will be realized.

riskometer

Investors understand that their principal will be at very high risk

5-Years History
financial year2018-20192019-20202020-2021
NAV in Rs (as on 04-Mar-2021)10.149.5417.57
Net Assets(Rs Crores) (as on 04-Mar-2021) 1497.55 1073.47 2010.14
Scheme Returns(%)(Absolute)1.40-6.3886.12
B'mark Returns(%)(Absolute)6.85-15.9579.79
Category Rank37/7315/7526/75
Quarterly performance - Last 5 years (Absolute Ret. in %)
financial year Q1 Q2 Q3 Q4
2020-202137.1122.3210.75NA
2019-2020-4.93-2.399.88-7.74
2018-2019NANA-5.362.63
Top 10 holdings
company (%)
Sun Pharmaceutical Industries...11.78 
Cipla Ltd.10.85 
Alkem Laboratories Ltd.7.80 
Ipca Laboratories Ltd.6.02 
Tata Chemicals Ltd.5.40 
Dr. Reddys Laboratories Ltd.5.39 
Lupin Ltd.4.59 
Divis Laboratories Ltd.4.57 
Cadila Healthcare Ltd.3.71 
Indoco Remedies Ltd.3.23 

Category

Sector Funds

Launch Date

13-Jul-18

Scheme Benchmark

S&P BSE HEALTH CARE

AUM ( in Cr.)

2,010.14

portfolio price to book value

4.77

investing style?

Large Growth

fund manager?

Dharmesh Kakkad,Priyanka Khandelwal

inception date (regular plan)

13-Jul-18

expense ratio (regular plan) %

2.40

Alpha [%]

0.14

Beta [%]

0.47

Top 10 sectors
sectors (%)
Pharmaceuticals & Drugs76.80
Hospital & Healthcare Services7.51
Chemicals 5.40
Miscellaneous2.92
Insurance2.02
Construction - Real Estate0.09

Historical NAV Chart with Benchmark

to go
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • maximum
performance comparision with similar schemes
scheme name investment style inception date AUM in Cr. 1W(%) 1M(%) 3M(%) 1Y(%) 3Y(%) 5Y(%) 10Y(%) since inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Large-Growth 13-Jul-20182,010.141.91-0.512.6362.38NANANA23.76BUYSIP
Nippon India Pharma Fund(G)Large-Growth 05-Jun-20044,197.032.65-1.093.2657.0321.4212.8617.2821.24BUYSIP
Tata India Pharma & Healthcare Fund-Reg(G)Large-Growth 28-Dec-2015408.241.72-1.991.8849.7319.298.37NA7.81BUYSIP
SBI Healthcare Opp Fund-Reg(G)Large-Growth 14-Jul-19991,551.451.22-1.673.6852.7816.687.4516.9015.63BUYSIP
UTI Healthcare Fund-Reg(G)Large-Growth 01-Aug-2005617.191.91-1.181.4755.3916.679.1913.9718.39BUYSIP
DSP Healthcare Fund-Reg(G)Large-Growth 30-Nov-20181,048.741.13-1.053.1958.16NANANA33.69BUYSIP
Mirae Asset Healthcare Fund-Reg(G)Large-Growth 02-Jul-20181,166.012.150.513.3657.80NANANA26.78BUYSIP
IDBI Healthcare Fund-Reg(G)Large-Growth 28-Feb-201965.021.61-0.670.6145.86NANANA27.77BUYSIP
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Large-Growth 10-Jul-2019441.971.70-1.411.9041.49NANANA33.56BUYSIP

Copyright © 2017 Vedant Asset. All Right Reserved.

Mutual Fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not an indicator of future returns. ARN-104974